A Multicenter Single-arm Prospective Clinical Study on First-line Treatment of Pancreatic Cancer Liver Metastases With Arterial Infusion Chemotherapy and Embolization Combined With Dual Immune Checkpoint Inhibitors.

NCT07333287 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

38

Enrollment

OTHER_GOV

Sponsor class

Conditions

Pancreatic Cancer Liver Metastases
Immunotherapy-naive

Interventions

PROCEDURE: Interventional
DRUG: Targeted Therapy (anti-VEGF)
DRUG: Immunotherapy + Targeted Therapy
DRUG: Immunotherapy + Targeted Therapy + Chemotherapy
OTHER: This cycle is repeated every 21 days.

Sponsor

Shandong Provincial Hospital